Correction to: Int J Hematol (2017) 106:704–710 https://doi.org/10.1007/s12185-017-2265-6
The authors would like to correct the error in Table 2 in the original publication of the article. The “Blood type” is not described in any part of “Results” and “Discussion” and had no impact on the conclusion hence the bottom of the table is removed.
The revised Table 2 is given in the following page for your reading.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1007/s12185-017-2265-6.
About this article
Cite this article
Nogami, K., Shima, M., Fukutake, K. et al. Correction to: Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations. Int J Hematol 107, 123–124 (2018). https://doi.org/10.1007/s12185-017-2369-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-017-2369-z